Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Connect Biopharma Holdings Ltd ADR
(NQ:
CNTB
)
1.270
+0.010 (+0.79%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Connect Biopharma Holdings Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket
March 21, 2023
Gainers Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 21, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 20, 2023
It's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement!
Via
InvestorPlace
Connect Biopharma Lead Candidate Aces Pivotal Atopic Dermatitis Trial In Chinese Patients
October 04, 2022
Via
Benzinga
Connect Biopharma's Candidate For Skin Disease-Associated Itch Shows Encouraging Safety Profile
August 30, 2022
Via
Benzinga
Connect Biopharma's Atopic Dermatitis Candidate Shows Rapid, Sustained Improvement Across All Body Regions
March 20, 2023
Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).
Via
Benzinga
Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms
March 18, 2023
From
Connect Biopharma Holdings Limited
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions
March 17, 2023
From
Connect Biopharma Holdings Limited
Via
Business Wire
Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting
March 06, 2023
From
Connect Biopharma Holdings Limited
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 02, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Thursday morning!
Via
InvestorPlace
Connect Biopharma To Present at Upcoming Investor and Scientific Conferences
October 27, 2022
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
Connect Biopharma Sees CBP-201 Topline Data From China Atopic Dermatitis Trial This Year
July 12, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 27, 2022
It's time for another dive into the biggest pre-market stock movers as we check out the latest stock news for Thursday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 18, 2022
It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 11, 2022
Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.
Via
Benzinga
Week In Review: AIM Vaccine Stages $20 Million IPO On Hong Kong Exchange
October 08, 2022
Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just $20 million, which netted the company only $10 million. Interest in the offering was low, with less than 1% of the...
Via
Talk Markets
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
October 05, 2022
Losers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 04, 2022
Gainers
Via
Benzinga
CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China
October 04, 2022
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in China
October 04, 2022
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic Dermatitis
October 03, 2022
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
Earnings Scheduled For September 13, 2022
September 13, 2022
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.19 per share on revenue of $42.62 million.
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 08, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 02, 2022
Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...
Via
Benzinga
Week In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology Investments
July 16, 2022
Qiming Venture Partners closed two new China healthcare and technology funds with $3.2 billion in fresh capital, both of them at their hard cap limits. The USD Fund VIII has $2.5 billion and the first...
Via
Talk Markets
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session
July 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.